These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19477805)

  • 1. The enduring menace of MRSA: incidence, treatment, and prevention in a county jail.
    Deger GE; Quick DW
    J Correct Health Care; 2009 Jul; 15(3):174-8. PubMed ID: 19477805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive community-associated MRSA infections: epidemiology and antimicrobial management.
    Pichereau S; Rose WE
    Expert Opin Pharmacother; 2010 Dec; 11(18):3009-25. PubMed ID: 20955116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Whitman TJ
    Dis Mon; 2008 Dec; 54(12):780-6. PubMed ID: 18996280
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Pallin DJ; Egan DJ; Pelletier AJ; Espinola JA; Hooper DC; Camargo CA
    Ann Emerg Med; 2008 Mar; 51(3):291-8. PubMed ID: 18222564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A; Raman S; Johnson M; Piehl M
    N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-acquired methicillin-resistant Staphylococcus aureus infections of the hand: prevalence and timeliness of treatment.
    O'Malley M; Fowler J; Ilyas AM
    J Hand Surg Am; 2009 Mar; 34(3):504-8. PubMed ID: 19258149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Creech CB; Beekmann SE; Chen Y; Polgreen PM
    Pediatr Infect Dis J; 2008 Mar; 27(3):270-2. PubMed ID: 18277924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children.
    Frei CR; Makos BR; Daniels KR; Oramasionwu CU
    J Pediatr Surg; 2010 Oct; 45(10):1967-74. PubMed ID: 20920714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Chambers HF
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and recurrence management of staphylococcal infections: community-acquired MRSA.
    Kale-Pradhan P; Johnson LB
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):909-15. PubMed ID: 19053903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.
    Moore CL; Hingwe A; Donabedian SM; Perri MB; Davis SL; Haque NZ; Reyes K; Vager D; Zervos MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):148-55. PubMed ID: 19394801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):919-22. PubMed ID: 11699844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for complicated skin and skin-structure infections.
    Mendoza N; Tyring SK
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):509-20. PubMed ID: 20557269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing MRSA infection in the community.
    Lautenbach E; Zaoutis T
    LDI Issue Brief; 2009 Aug; 14(6):1-4. PubMed ID: 19780236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics, skin and soft tissue infection and meticillin-resistant Staphylococcus aureus: cause and effect.
    Gould IM
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S8-11. PubMed ID: 19560675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current challenges in treating MRSA: what are the options?
    Ratnaraja NV; Hawkey PM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):601-18. PubMed ID: 18847401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of community-associated MRSA as a result of the unmasking effect of antibiotic treatment.
    Cheng VC; Chan JF; To KK; Tai JW; Ho PL
    J Hosp Infect; 2009 Jul; 72(3):273-4. PubMed ID: 19446364
    [No Abstract]   [Full Text] [Related]  

  • 20. Dermatologists' perceptions and practices related to community-associated methicillin-resistant Staphylococcus aureus infections.
    Brinsley-Rainisch KJ; Cochran RL; Pearson ML
    Am J Infect Control; 2008 Nov; 36(9):668-71. PubMed ID: 18834745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.